Revolution Medicines Inc (RVMD)

Apr 27, 2025

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC - GuruFocus

Apr 27, 2025

Apr 27, 2025

Revolution Medicines Reports Promising Clinical Data for Zoldonrasib in KRAS G12D Mutant Non-Small Cell Lung Cancer at AACR Annual Meeting - Nasdaq

Apr 27, 2025

Apr 27, 2025

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting - GlobeNewswire

Apr 27, 2025

Apr 27, 2025

Revolutionary KRAS Cancer Drug Achieves 61% Response Rate in Lung Cancer PatientsKey Trial Data Released - Stock Titan

Apr 27, 2025

Apr 26, 2025

Russell Investments Group Ltd. Increases Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Apr 26, 2025

Apr 25, 2025

Revolution Medicines Inc (RVMD) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Apr 25, 2025

Apr 24, 2025

RVMD Stock Sees Surge of Approximately 3.08% in Last Five Days - knoxdaily.com

Apr 24, 2025

Apr 22, 2025

This trade activity should not be overlooked: Revolution Medicines Inc (RVMD) - Sete News

Apr 22, 2025

Apr 21, 2025

Revolution Medicines Inc [RVMD] stock was sold by Cislini Jeff at the price of US$79008.0 - knoxdaily.com

Apr 21, 2025

Apr 20, 2025

Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewswire

Apr 20, 2025

Apr 09, 2025

Revolution Medicines at Stifel Forum: RAS-Driven Cancer Insights By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 08, 2025

Revolution Medicines: Overpriced RAS-Addicted Cancers Maven (NASDAQ:RVMD) - Seeking Alpha

Apr 08, 2025

Apr 07, 2025

Revolution Medicines stock hits 52-week low at $30.02 - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Revolution Medicines at Needham Conference: Progress in Cancer Treatment - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Revolution Medicines at Needham Conference: Progress in Cancer Treatment By Investing.com - Investing.com Canada

Apr 07, 2025

Apr 07, 2025

Revolution Medicines stock hits 52-week low at $30.02 By Investing.com - Investing.com India

Apr 07, 2025

Apr 03, 2025

Revolution Medicines Inc [RVMD] Records 50-Day SMA of $39.97 - knoxdaily.com

Apr 03, 2025

Apr 02, 2025

When the Price of (RVMD) Talks, People Listen - news.stocktradersdaily.com

Apr 02, 2025

Apr 01, 2025

Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times

Apr 01, 2025

Apr 01, 2025

Revolution Medicines to Deliver Multiple Presentations at - GlobeNewswire

Apr 01, 2025

Mar 31, 2025

Revolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy Now - MSN

Mar 31, 2025

Mar 31, 2025

Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums - Stock Titan

Mar 31, 2025

Mar 31, 2025

Revolution Medicines Inc [RVMD] Stock sold by Insider Cislini Jeff for $79008.0 - knoxdaily.com

Mar 31, 2025

Mar 30, 2025

Is Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 30, 2025

Mar 26, 2025

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Mar 26, 2025

Mar 24, 2025

Revolution Medicines general counsel Jeff Cislini sells $79,008 in stock By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Revolution Medicines general counsel Jeff Cislini sells $79,008 in stock - Investing.com

Mar 24, 2025

Mar 24, 2025

Taking a Closer Look At Revolution Medicines Inc (RVMD) Following Its Recent Trade - knoxdaily.com

Mar 24, 2025

Mar 20, 2025

Revolution Medicines executive sells shares worth $128,598 By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Revolution Medicines’ general counsel sells $56,920 in stock By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 19, 2025

Revolution Medicines CEO Mark Goldsmith sells $458,255 in stock By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Revolution Medicines CFO Jack Anders sells $72,771 in stock By Investing.com - Investing.com Canada

Mar 19, 2025

Mar 19, 2025

Revolution Medicines’ general counsel sells $56,920 in stock - Investing.com India

Mar 19, 2025

Mar 19, 2025

Revolution Medicines CFO Jack Anders sells $72,771 in stock - Investing.com

Mar 19, 2025

Mar 19, 2025

Revolution Medicines Executives Sell Shares - TradingView

Mar 19, 2025

Mar 19, 2025

Revolution Medicines COO Margaret Horn sells $119,385 in stock - Investing.com

Mar 19, 2025

Mar 15, 2025

Revolution Medicines Inc (RVMD) Should Be Considered For The Next Few Weeks - Stocks Register

Mar 15, 2025

Mar 13, 2025

Earnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 20 - GuruFocus.com

Mar 13, 2025

Mar 13, 2025

Revolution Medicines at Leerink Conference: Expanding RAS Inhibitor Reach By Investing.com - Investing.com Canada

Mar 13, 2025

Mar 12, 2025

Revolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trials - Investing.com Canada

Mar 12, 2025

Mar 12, 2025

Revolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trials By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Revolution Medicines at Barclays Conference: Focus on Pancreatic Cancer Trials - Investing.com UK

Mar 11, 2025

Mar 08, 2025

Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers - ACS Publications

Mar 08, 2025

Mar 06, 2025

Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey

Mar 06, 2025

Mar 04, 2025

10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey

Mar 04, 2025

Mar 04, 2025

Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs - TipRanks

Mar 04, 2025

Mar 04, 2025

HC Wainwright Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - Defense World

Mar 04, 2025